Answer
No, a subcutaneous dose of 0.3 mg/kg methylnaltrexone bromide did not significantly affect the metabolism of dextromethorphan, a CYP2D6 substrate, in healthy adult men.
Sources for this answer
- Relistor 12mg/0.6ml solution for injection vialsBausch Health Ireland Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 1Document updated
Sources checked